Symbols

APLT(Delisted)

Applied Therapeutics·NASDAQ

--(--)

APLT fundamentals

APLT Q2 2025 Earnings

Applied Therapeutics (APLT) released its earnings on Aug 13, 2025: revenue was 0 (YoY -100.00%), missed estimates; EPS was -0.15 (YoY -15.38%), beat estimates.

Revenue / YoY

-100.00%

EPS / YoY

-0.15

-15.38%

Report date

Aug 13, 2025

Earnings Call

9:30 AM on Aug 13, 2025

Meeting link.

Earnings

EPS

Revenue

Revenue & Expenses

APLT has released its 2025 Q3 earnings report, with revenue of 1.00M, reflecting a YoY change of 719.67%, and net profit of -18.99M, showing a YoY change of 72.31%. The Sankey diagram below clearly presents APLT's revenue sources and cost distribution.

Key Indicators

Applied Therapeutics (APLT) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Applied Therapeutics (APLT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Applied Therapeutics (APLT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Applied Therapeutics (APLT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown

Revenue Breakdown

Where does Applied Therapeutics (APLT) generate its revenue? Explore its key revenue streams and top earning regions.

By Business

Data source:

By Region

Data source:

Dividend

Track Applied Therapeutics (APLT) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History

Payout Ratio

Dividend Yield

You can ask Aime

No Data